Reversible pseudoatrophy of the brain and mental deterioration associated with valproate treatment.
about
Chronic divalproex sodium use and brain atrophy in Alzheimer diseaseSodium valproate use is associated with reduced parietal lobe thickness and brain volumeSafety and tolerability of antiepileptic drug treatment in children with epilepsy.Deformation-based morphometry of prospective neurodevelopmental changes in new onset paediatric epilepsy.Idiosyncratic adverse reactions to antiepileptic drugs.Cortical and subcortical brain alterations in Juvenile Absence Epilepsy.Valproate: a practical review of its uses in neurological and psychiatric disorders.Measurable Supratentorial White Matter Volume Changes in Patients with Diffuse Intrinsic Pontine Glioma Treated with an Anti-Vascular Endothelial Growth Factor Agent, Steroids, and Radiation.Ultrastructure of Purkinje cell perikarya and their dendritic processes in the rat cerebellar cortex in experimental encephalopathy induced by chronic application of valproate.Ultrastructure of astrocytes in the cortex of the hippocampal gyrus and in the neocortex of the temporal lobe in experimental valproate encephalopathy and after valproate withdrawal.Suicidality induced by steroid treatment.Thalamic volume reduction in drug-naive patients with new-onset genetic generalized epilepsy.Brain MRI findings in severe myoclonic epilepsy in infancy and genotype-phenotype correlations.Evaluation of deep gray matter volume, cortical thickness and white matter integrity in patients with typical absence epilepsy: a study using voxelwise-based techniques.Association of chronic divalproex sodium use and brain atrophy in Alzheimer's disease.
P2860
Q30424864-3DED47BB-9102-45B4-A311-A6CE7EFD28DEQ30570226-05A555F4-49A4-47EB-BA03-E0A81EC3ABDFQ34281872-9568CB24-8E9A-4972-990F-EBEF2AC3A8C7Q34754651-AA185D11-384D-48A9-808B-38CB34E8262EQ36770454-F2281F32-36FE-4E69-AB4D-5F7C5D591836Q37172635-B371B3DD-ECFC-4442-AC01-E3863478D8D7Q37610273-7965E7A3-64F0-4BA6-BFF4-69076C637C2AQ38827788-D986EA68-20ED-4870-BFDC-0E5F2589DF48Q43887806-A2B5FA4B-B902-43E8-BDF4-7E6C6FDB8D8BQ44585274-19F6F572-78F9-40FB-AD39-015584B48D96Q46042857-E8FE8914-FA40-49A9-A020-3914FED35463Q47336146-6803AE04-A83D-48D7-80FB-04DAF13E7F8AQ48230460-E9C0E726-B15A-40CF-85AF-5BE9B4707354Q48359470-9C3E389A-86A6-496E-A29B-FDEAD469C85EQ48685306-C7F708F6-D783-4EA7-8FF4-757B294F3DA6
P2860
Reversible pseudoatrophy of the brain and mental deterioration associated with valproate treatment.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Reversible pseudoatrophy of th ...... ated with valproate treatment.
@en
Reversible pseudoatrophy of th ...... ated with valproate treatment.
@nl
type
label
Reversible pseudoatrophy of th ...... ated with valproate treatment.
@en
Reversible pseudoatrophy of th ...... ated with valproate treatment.
@nl
prefLabel
Reversible pseudoatrophy of th ...... ated with valproate treatment.
@en
Reversible pseudoatrophy of th ...... ated with valproate treatment.
@nl
P2093
P2860
P1433
P1476
Reversible pseudoatrophy of th ...... ated with valproate treatment.
@en
P2093
Belmonte A
Canapicchi R
Casalini C
Guerrini R
P2860
P356
10.1111/J.1528-1157.1998.TB01270.X
P577
1998-01-01T00:00:00Z